Clinical Trial Site

Dayton, Ohio 45459

3 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer, Generalized Myasthenia Gravis, HER2 Negative Breast Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Iron Deficiency Anemia, Metastatic Breast Cancer

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed